These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 19279091)

  • 1. A limited group of class I histone deacetylases acts to repress human immunodeficiency virus type 1 expression.
    Keedy KS; Archin NM; Gates AT; Espeseth A; Hazuda DJ; Margolis DM
    J Virol; 2009 May; 83(10):4749-56. PubMed ID: 19279091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of latent human immunodeficiency type 1 is induced by novel and selective histone deacetylase inhibitors.
    Archin NM; Keedy KS; Espeseth A; Dang H; Hazuda DJ; Margolis DM
    AIDS; 2009 Sep; 23(14):1799-806. PubMed ID: 19590405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitors of histone deacetylases: correlation between isoform specificity and reactivation of HIV type 1 (HIV-1) from latently infected cells.
    Huber K; Doyon G; Plaks J; Fyne E; Mellors JW; Sluis-Cremer N
    J Biol Chem; 2011 Jun; 286(25):22211-8. PubMed ID: 21531716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective HDAC inhibition for the disruption of latent HIV-1 infection.
    Barton KM; Archin NM; Keedy KS; Espeseth AS; Zhang YL; Gale J; Wagner FF; Holson EB; Margolis DM
    PLoS One; 2014; 9(8):e102684. PubMed ID: 25136952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Naf1 Regulates HIV-1 Latency by Suppressing Viral Promoter-Driven Gene Expression in Primary CD4+ T Cells.
    Li C; Wang HB; Kuang WD; Ren XX; Song ST; Zhu HZ; Li Q; Xu LR; Guo HJ; Wu L; Wang JH
    J Virol; 2017 Jan; 91(1):. PubMed ID: 27795436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The histone deacetylase inhibitor vorinostat (SAHA) increases the susceptibility of uninfected CD4+ T cells to HIV by increasing the kinetics and efficiency of postentry viral events.
    Lucera MB; Tilton CA; Mao H; Dobrowolski C; Tabler CO; Haqqani AA; Karn J; Tilton JC
    J Virol; 2014 Sep; 88(18):10803-12. PubMed ID: 25008921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective targeting of the repressive transcription factors YY1 and cMyc to disrupt quiescent human immunodeficiency viruses.
    Barton K; Margolis D
    AIDS Res Hum Retroviruses; 2013 Feb; 29(2):289-98. PubMed ID: 22866663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Counterregulation of chromatin deacetylation and histone deacetylase occupancy at the integrated promoter of human immunodeficiency virus type 1 (HIV-1) by the HIV-1 repressor YY1 and HIV-1 activator Tat.
    He G; Margolis DM
    Mol Cell Biol; 2002 May; 22(9):2965-73. PubMed ID: 11940654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hexamethylbisacetamide and disruption of human immunodeficiency virus type 1 latency in CD4(+) T cells.
    Choudhary SK; Archin NM; Margolis DM
    J Infect Dis; 2008 Apr; 197(8):1162-70. PubMed ID: 18419522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV-1 Vpr reactivates latent HIV-1 provirus by inducing depletion of class I HDACs on chromatin.
    Romani B; Kamali Jamil R; Hamidi-Fard M; Rahimi P; Momen SB; Aghasadeghi MR; Allahbakhshi E
    Sci Rep; 2016 Aug; 6():31924. PubMed ID: 27550312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. c-Myc and Sp1 contribute to proviral latency by recruiting histone deacetylase 1 to the human immunodeficiency virus type 1 promoter.
    Jiang G; Espeseth A; Hazuda DJ; Margolis DM
    J Virol; 2007 Oct; 81(20):10914-23. PubMed ID: 17670825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The human factors YY1 and LSF repress the human immunodeficiency virus type 1 long terminal repeat via recruitment of histone deacetylase 1.
    Coull JJ; Romerio F; Sun JM; Volker JL; Galvin KM; Davie JR; Shi Y; Hansen U; Margolis DM
    J Virol; 2000 Aug; 74(15):6790-9. PubMed ID: 10888618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polyamides reveal a role for repression in latency within resting T cells of HIV-infected donors.
    Ylisastigui L; Coull JJ; Rucker VC; Melander C; Bosch RJ; Brodie SJ; Corey L; Sodora DL; Dervan PB; Margolis DM
    J Infect Dis; 2004 Oct; 190(8):1429-37. PubMed ID: 15378435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Entinostat is a histone deacetylase inhibitor selective for class 1 histone deacetylases and activates HIV production from latently infected primary T cells.
    Wightman F; Lu HK; Solomon AE; Saleh S; Harman AN; Cunningham AL; Gray L; Churchill M; Cameron PU; Dear AE; Lewin SR
    AIDS; 2013 Nov; 27(18):2853-62. PubMed ID: 24189584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PIWIL4 Maintains HIV-1 Latency by Enforcing Epigenetically Suppressive Modifications on the 5' Long Terminal Repeat.
    He Z; Jing S; Yang T; Chen J; Huang F; Zhang W; Peng Z; Liu B; Ma X; Wu L; Pan T; Zhang X; Li L; Cai W; Tang X; Zhang J; Zhang H
    J Virol; 2020 May; 94(10):. PubMed ID: 32161174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NF-kappaB p50 promotes HIV latency through HDAC recruitment and repression of transcriptional initiation.
    Williams SA; Chen LF; Kwon H; Ruiz-Jarabo CM; Verdin E; Greene WC
    EMBO J; 2006 Jan; 25(1):139-49. PubMed ID: 16319923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histone deacetylase inhibitor romidepsin induces HIV expression in CD4 T cells from patients on suppressive antiretroviral therapy at concentrations achieved by clinical dosing.
    Wei DG; Chiang V; Fyne E; Balakrishnan M; Barnes T; Graupe M; Hesselgesser J; Irrinki A; Murry JP; Stepan G; Stray KM; Tsai A; Yu H; Spindler J; Kearney M; Spina CA; McMahon D; Lalezari J; Sloan D; Mellors J; Geleziunas R; Cihlar T
    PLoS Pathog; 2014 Apr; 10(4):e1004071. PubMed ID: 24722454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coaxing HIV-1 from resting CD4 T cells: histone deacetylase inhibition allows latent viral expression.
    Ylisastigui L; Archin NM; Lehrman G; Bosch RJ; Margolis DM
    AIDS; 2004 May; 18(8):1101-8. PubMed ID: 15166525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Posttranscriptional Regulation of HIV-1 Gene Expression during Replication and Reactivation from Latency by Nuclear Matrix Protein MATR3.
    Sarracino A; Gharu L; Kula A; Pasternak AO; Avettand-Fenoel V; Rouzioux C; Bardina M; De Wit S; Benkirane M; Berkhout B; Van Lint C; Marcello A
    mBio; 2018 Nov; 9(6):. PubMed ID: 30425153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of latent HIV induced by the potent HDAC inhibitor suberoylanilide hydroxamic acid.
    Archin NM; Espeseth A; Parker D; Cheema M; Hazuda D; Margolis DM
    AIDS Res Hum Retroviruses; 2009 Feb; 25(2):207-12. PubMed ID: 19239360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.